Search

Author/Creator Hwang, Clara

2. Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems. Issue 5 (20th May 2021)

Authors:
Hwang, Clara; Izano, Monika A.; Thompson, Michael A.; Gadgeel, Shirish M.; Weese, James L.; Mikkelsen, Tom; Schrag, Andrew; Teka, Mahder; Walters, Sheetal; Wolf, Frank M.; Hirsch, Jonathan; Rivera, Donna R.; Kluetz, Paul G.; Singh, Harpreet; Brown, Thomas D.
Journal:
Cancer reports
Issue:
Volume 4:Issue 5(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study. (14th February 2022)

Authors:
Satyanarayana, Gowri; Enriquez, Kyle T; Sun, Tianyi; Klein, Elizabeth J; Abidi, Maheen; Advani, Shailesh M; Awosika, Joy; Bakouny, Ziad; Bashir, Babar; Berg, Stephanie; Bernardes, Marilia; Egan, Pamela C; Elkrief, Arielle; Feldman, Lawrence E; Friese, Christopher R; Goel, Shipra; Gomez, Cyndi Gon...
Journal:
Open forum infectious diseases
Issue:
Volume 9:Number 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9 (September 2022)

Authors:
Powles, Thomas; Tomczak, Piotr; Park, Se Hoon; Venugopal, Balaji; Ferguson, Thomas; Symeonides, Stefan N; Hajek, Jaroslav; Gurney, Howard; Chang, Yen-Hwa; Lee, Jae Lyun; Sarwar, Naveed; Thiery-Vuillemin, Antoine; Gross-Goupil, Marine; Mahave, Mauricio; Haas, Naomi B; Sawrycki, Piotr; Burgents, Jo...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 9(2022)
Page Start:
1133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A novel prognostic model predicting overall survival in patients with metastatic castration‐resistant prostate cancer receiving standard chemotherapy: A multi‐trial cohort analysis. Issue 13 (5th July 2022)

Authors:
Modonutti, Daniele; Majdalany, Sami E.; Corsi, Nicholas; Li, Pin; Sood, Akshay; Dalela, Deepansh; Jamil, Marcus L.; Hwang, Clara; Menon, Mani; Rogers, Craig G.; Trinh, Quoc‐Dien; Novara, Giacomo; Abdollah, Firas
Journal:
Prostate
Issue:
Volume 82:Issue 13(2022)
Page Start:
1293
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Issue 7 (July 2021)

Authors:
Powles, Thomas; Csőszi, Tibor; Özgüroğlu, Mustafa; Matsubara, Nobuaki; Géczi, Lajos; Cheng, Susanna Y-S; Fradet, Yves; Oudard, Stephane; Vulsteke, Christof; Morales Barrera, Rafael; Fléchon, Aude; Gunduz, Seyda; Loriot, Yohann; Rodriguez-Vida, Alejo; Mamtani, Ronac; Yu, Evan Y; Nam, Kijoeng; Imai...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 7(2021)
Page Start:
931
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗